ARMGO Pharma Inc., a NY-based biotech company is looking for a full-time patent agent to join our team. The patent agent will play a pivotal role in developing and managing ARMGO’s growing patent portfolio and will provide assistance to the general counsel in all matters relating to intellectual property. This position offers the opportunity to work closely with the research and development teams, to help identify, advance and protect innovations.
Qualifications:
- Qualified candidates will have at least three (3) years of patent preparation and prosecution experience, specifically within the field of organic or medicinal chemistry, pharmacology or biochemistry.
- Experience with preparing and prosecuting small molecule patent applications is required. Foreign prosecution experience is strongly preferred.
- Law firm experience in a firm focusing on technology and life sciences companies is a plus.
- Advanced degree (PhD preferred) in chemistry, biochemistry or related discipline.
- Experience in due diligence and landscape analysis is strongly preferred.
- Registration to practice before the USPTO is required.
Responsibilities:
- Your responsibilities will include patent drafting and prosecution, competitive surveillance, patent portfolio oversight and maintenance, evaluating new scientific advances and invention disclosures.
- Conduct patent searches, assist with patentability and freedom to operate analysis.
- Work closely with outside counsel to handle all deadlines and filings related to the company’s proprietary and licensed IP portfolio.
- Provide assistance to the general counsel in all matters related to IP.
This is a fully remote position, candidates from across the United States are welcome to apply. Must be flexible to participate in virtual meetings with collaborators in Europe.
ARMGO provides a full benefit package for full time employees, including comprehensive medical, dental and vision plans, 401K, flexible spending accounts, supplemental life insurance, supplemental AD&D insurance, among others.
About ARMGO
ARMGO Pharma is a privately owned, venture-backed, biotech company that is developing small molecule drugs that repair leaky Ryanodine Receptor (RyR) calcium channels associated with human diseases. We hold an exclusive, worldwide license from Columbia University for its RyR technology and know-how.
Our primary focus is on two orphan diseases: the life-threatening cardiac disease Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT), and the severe muscle disease RYR1-Related Myopathy (RYR1-RM). The two conditions occur due to genetic mutations in the RYR genes. Mutations in RYR2 can lead to cardiac arrhythmias and sudden cardiac death, while mutations in RYR1 can cause muscle weakness.
ARMGO’s molecules, termed Rycals® are designed to repair leaky RyR channels. Since the cause of the symptoms of CPVT and RYR1-RM is abnormal calcium leak due to these mutations, Rycals® hold the promise of disease-modifying therapy for these two orphan genetic diseases. Beyond these genetic conditions Rycals® have therapeutic potential for other disorders associated with leaky RyRs.